Durvalumab increases the risk of radiation pneumonitis in non-small-cell lung cancer patients

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Pages (from-to)S323-S324
    Number of pages2
    JournalRadiotherapy and Oncology
    Volume170
    Publication statusPublished - May-2022

    Cite this